MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Explore how genetic testing aids in diagnosing Acne Inversa, Familial, 3, offering insights into treatment, family planning, and personalized healthcare strategies.
Explore the impact of genetic testing on diagnosing Agammaglobulinemia 2, autosomal recessive. Uncover pathways for early detection, personalized treatment, and family planning.
Explore Agammaglobulinemia 3, its genetic roots, and the pivotal role of genetic testing in diagnosis, treatment strategies, and informed family planning.
Unlock the potential of genetic testing for Agammaglobulinemia 4. Learn about diagnosis, treatment strategies, and genetic counseling in managing this rare disorder.
Explore how genetic testing improves diagnosis and treatment of Agammaglobulinemia 5, autosomal dominant. Enhance care with personalized insights and planning.
Genetic testing reveals risks for Age-Related Macular Degeneration 5. Early diagnosis and personalized plans enhance eye health and empower informed decisions.
Genetic testing transforms ARMD6 care by predicting progression, personalizing treatments, and enabling early diagnosis of this macular degeneration subtype.
Explore genetic testing's role in ARMD8 to enhance early detection, create personalized treatments, and guide family planning strategies effectively.